IL17A and Pain: Recent studies have shown that the Th1-related immune response could induce the occurrence and progression of prostatic inflammation and chronic pelvic pain, and the absence of Th1-related cytokines could significantly reduce EAP susceptibility, while IL-17 was not required for pathological induction and development of chronic pelvic pain (20).